Cargando…
KUS121, an ATP regulator, mitigates chorioretinal pathologies in animal models of age-related macular degeneration
Age-related macular degeneration (AMD) is a leading cause of blindness among elderly people. The appearance of drusen is a clinical manifestation and a harbinger of both exudative and atrophic AMD. Recently, antibody-based medicines have been used to treat the exudative type. However, they do not re...
Autores principales: | Muraoka, Yuki, Iida, Yuto, Ikeda, Hanako O., Iwai, Sachiko, Hata, Masayuki, Iwata, Takeshi, Nakayama, Mao, Shimozawa, Nobuhiro, Katakai, Yuko, Kakizuka, Akira, Yoshimura, Nagahisa, Tsujikawa, Akitaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986307/ https://www.ncbi.nlm.nih.gov/pubmed/29872758 http://dx.doi.org/10.1016/j.heliyon.2018.e00624 |
Ejemplares similares
-
KUS121 attenuates the progression of monosodium iodoacetate-induced osteoarthritis in rats
por: Iwai, Sachiko, et al.
Publicado: (2021) -
KUS121, a VCP modulator, attenuates ischemic retinal cell death via suppressing endoplasmic reticulum stress
por: Hata, Masayuki, et al.
Publicado: (2017) -
Neuoroprotective efficacies by KUS121, a VCP modulator, on animal models of retinal degeneration
por: Hasegawa, Tomoko, et al.
Publicado: (2016) -
Safety and effectiveness of a novel neuroprotectant, KUS121, in patients with non-arteritic central retinal artery occlusion: An open-label, non-randomized, first-in-humans, phase 1/2 trial
por: Ikeda, Hanako Ohashi, et al.
Publicado: (2020) -
A VCP modulator, KUS121, as a promising therapeutic agent for post-traumatic osteoarthritis
por: Saito, Motoo, et al.
Publicado: (2020)